☆ 4.7 Article

Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial

SCIENTIFIC REPORTS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Endocrinology & Metabolism

Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis

Ahmad Fariz Malvi Zamzam Zein et al.

Summary: This systematic review and meta-analysis suggests an association between colchicine and reduced mortality in patients with COVID-19, although the analysis of randomized trials did not show a significant effect of colchicine on mortality.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model

Alberto Cecconi et al.

Summary: The study found that colchicine may stabilize atherosclerotic plaque by reducing inflammatory activity and plaque burden, particularly in animals with high cholesterol levels.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)

添加到收藏夹

Letter Medicine, General & Internal

Regardless of Age, Obesity and Hypertension Increase Risks With COVID-19

Mitchell H. Katz

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Review Rheumatology

Anti-inflammatory therapy for COVID-19 infection: the case for colchicine

Aaron Z. Reyes et al.

Summary: The search for effective COVID-19 management strategies is ongoing, with colchicine showing promise in targeting multiple mechanisms associated with excessive inflammation. Outpatient treatment with colchicine could potentially reduce the need for hospitalization and mortality due to COVID-19, benefiting both resource-replete and resource-poor regions by reducing the demand for rare or expensive care resources.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

Rafael Diaz et al.

Summary: The study concludes that colchicine did not significantly reduce the need for mechanical ventilation or 28-day mortality in hospitalized patients with COVID-19 pneumonia.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Infectious Diseases

Effects of early corticosteroid use in patients with severe coronavirus disease 2019

Jong Hoon Hyun et al.

Summary: The study found that early use of corticosteroids in patients with severe COVID-19 showed favorable clinical outcomes related to a reduction in the length of hospital stay.

BMC INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study

Min Gao et al.

Summary: The study found that above a BMI of 23 kg/m(2), there is a linear increase in the risk of severe consequences of COVID-19 leading to hospital admission and death, and a linear increase in ICU admission risk across the entire BMI range. The impact of increasing BMI is particularly notable in individuals younger than 40 years and of Black ethnicity.

LANCET DIABETES & ENDOCRINOLOGY (2021)

添加到收藏夹

Article Critical Care Medicine

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

Jean-Claude Tardif et al.

Summary: The study aimed to investigate the effect of colchicine on the composite of COVID-19-related death or hospital admission. Among patients with PCR-confirmed COVID-19, colchicine led to a lower rate of the composite of death or hospital admission than placebo.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Critical Care Medicine

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Group Author Only

Summary: The study aimed to evaluate the efficacy and safety of colchicine in treating COVID-19 patients, but found that it did not reduce 28-day mortality, hospital stay duration, or risk of progressing to invasive mechanical ventilation or death.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Rheumatology

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Maria Isabel Lopes et al.

Summary: Colchicine showed benefits in the treatment of COVID-19 patients by reducing the need for supplemental oxygen and length of hospitalisation. It did not necessarily reduce mortality, but was safe and well tolerated with the potential side effect of diarrhea.

RMD OPEN (2021)

添加到收藏夹

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China

Qingxian Cai et al.

DIABETES CARE (2020)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

COVID-19 Fulminant Myocarditis Successfully Treated With Temporary Mechanical Circulatory Support

Jorge Salamanca et al.

JACC-CARDIOVASCULAR IMAGING (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial

Spyridon G. Deftereos et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom

Mark Hamer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome

Diletta Cozzi et al.

RADIOLOGIA MEDICA (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Colchicine for Secondary Cardiovascular Prevention in Coronary Disease

Francois Roubille et al.

CIRCULATION (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Hannah Peckham et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial

Andrew P. Demidowich et al.

DIABETES OBESITY & METABOLISM (2019)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean-Claude Tardif et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Review Rheumatology

Colchicine-Update on mechanisms of action and therapeutic uses

Ying Ying Leung et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.